SCHEMBL17878498

SCHEMBL17878498

Brc1cc(Br)cc(-c2ccc3cc(N(c4ccccc4)c4ccc5ccccc5c4)ccc3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.40
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
ACMSD Q8TDX5 1/20 0.40
ALOX5 P09917 1/20 0.39
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
ALDH1A1 P00352 4/20 0.36
CYP1A2 P05177 3/20 0.36
KDM4E B2RXH2 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GSTP1 P09211 1/20 0.36
CYP11B1 P15538 2/20 0.36
CYP11B2 P19099 2/20 0.36
CYP17A1 P05093 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17878475 0.97 ALDH1A1 (0.37) CYP2A6ESR1ESR2ACMSDALOX5
SCHEMBL17878470 0.95 CYP2A6 (0.41) CYP2A6ESR1ESR2ACMSDALOX5
SCHEMBL17878477 0.95 CYP2A6 (0.41) CYP2A6ESR1ESR2ACMSDALOX5
SCHEMBL17878500 0.94 ESR1 (0.42) ESR1ESR2ACMSDHSD17B1HSD17B2
SCHEMBL17878492 0.91 CYP2A6 (0.38) CYP2A6ESR1ESR2ACMSDALOX5
SCHEMBL20313428 0.88 ESR1 (0.48) ESR1ESR2ACMSDALOX5HSD17B1
SCHEMBL556519 0.88 CYP2A6 (0.53) CYP2A6ESR1ESR2ACMSDALOX5
SCHEMBL17878469 0.87 CYP2A6 (0.45) CYP2A6ALDH1A1CYP1A2KDM4EMEN1
SCHEMBL24153962 0.87 ESR1 (0.52) ESR1ESR2ACMSDALOX5HSD17B1
SCHEMBL23095516 0.87 ESR1 (0.52) ESR1ESR2ACMSDALOX5HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957441-B2 Amine-based compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-05-01 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160190467-A1 AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, TYR, TAAR1 CYP2A6 1331/4885ESR1 56/4885ESR2 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.